In early 2003, during the planning for the initial in-house pharmacy, Thundermist began formulating plans to expand the availability and access of integrated pharmaceutical care to other underserved sectors in the state. To keep costs as low as possible, the organization began to seek nontraditional ways to accomplish this goal. While attending several health care [...]
In: Main
27 Apr 2010Thundermist has identified several significant health needs and concerns of the medically underserved and has responded with a variety of service options, including:
increased health services for its targeted patients. To address the lack of these services in the community, Thundermist implemented a mental health program, including psychotherapy, evaluations, crisis intervention, and psycho-pharmacological medication management.
chronic disease-prevention [...]
In: Main
26 Apr 2010Introduction
The development and application of new and improved technology have had a dramatic impact in the health care field. Advances in diagnostic procedures and devices, medical implants, and surgical techniques are revolutionizing medical care. However, technology has been slow to assist patients living in remote service areas and segments of the population who have historically [...]
In: Main
19 Apr 2010Imagine if you sat atop an organization whose mission for more than a century and a half was to boldly send nurses, home health aides, physicians, and others into every neighborhood, rich and poor, throughout the greater New York City area. Now you know what the Visiting Nurse Service of New York
In: Main
17 Apr 2010Conrad and colleagues established the efficacy of IR-OME in reducing the risk of 3 through 14 that had not cleared with 100 ml or more of lavage. Because this was a non-inferiority study, the primary efficacy analysis was conducted on the per-protocol population at the one-sided a = 0.025 level of significance.
In: Main
16 Apr 2010Older age produces a slight decrease in the elimination rate of omeprazole canadian and increases its bioavailability. Compared with a bioavailability of 58% in younger subjects, the bioavailability of a single 40-mg dose of IR-OME in healthy older subjects was 76%. The extent of metabolite excretion in the urine (70%) was similar to that observed in [...]
In: Main
15 Apr 2010Approximately one year ago, the U.S. Food and Drug Administration (FDA) approved a unique IR formulation of generic omeprazole (Zegerid) to treat a variety of acid-related disorders and to reduce the risk of upper gastrointestinal bleeding in critically ill patients (Table 1). This compound was developed by combining a highly effective PPI (omeprazole) with an [...]
Blog invites submissions of review articles, reports on clinical techniques, case reports, conference summaries, and articles of opinion pertinent to the control of pain and anxiety in dentistry.